Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.35 |
| ▸ | DGKA | P23743 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9839286 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL9837823 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL9839311 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL9839288 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL23853740 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL23854006 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL23854005 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL23853741 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL9837819 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A | |
| SCHEMBL9839314 | 1.00 | NAAA (0.39) | NAAAMEN1THRBHTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3883913-B1 | PROCESS FOR MAKING ETHERS VIA ENOL ETHERS | BP PLC (GB) | 2023-11-01 | — | — | EP | disclosed |
| US-11787760-B2 | Process for making ethers via enol ethers | BP P.L.C. (GB) | 2023-10-17 | — | — | US | disclosed |
| US-11787760-B2 | Process for making ethers via enol ethers | BP P.L.C. (GB) | 2023-10-17 | — | — | US | disclosed |
| US-20220002220-A1 | Process for Making Ethers via Enol Ethers | BP P.L.C. (GB) | 2022-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787760-B2 | Process for making ethers via enol ethers | ELOVL5, ELOVL1, ELOVL3 | NAAA 1678/4885MEN1 2508/4885THRB 4690/4885 |
| US-20220002220-A1 | Process for Making Ethers via Enol Ethers | ELOVL5, ELOVL1, ELOVL3 | NAAA 1678/4885MEN1 2508/4885THRB 4690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.